Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Clindamycin (topical): Clascoterone has the stronger overall evidence (7 vs 6.5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Clascoterone wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Clascoterone and Clindamycin (topical) have evidence — compare verdict strength side-by-side.
Apply a thin layer of clascoterone 1% cream to the affected area twice daily, morning and evening, on clean dry skin
Morning and evening
Clascoterone 1% cream
Clindamycin phosphate 1% gel, lotion or solution applied to the affected area once or twice daily, depending on the product. It should be used WITH benzoyl peroxide or a topical retinoid rather than alone, and for a limited course rather than indefinitely. A prescription medicine and a clinician's decision.
morning
Fixed-dose clindamycin 1% with benzoyl peroxide
immediate
12 weeks
12 weeks
1-4 weeks
long-term
long-term
long-term
long-term
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · Rct · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · Rct · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Topical antibiotic monotherapy only provides mild benefit for patients with acne vulgaris: a systematic review and network meta-analysis
Clin Drug Investig (2026) · Meta analysis · n=22645
32 studies comprising 34 randomised controlled trials, 22,645 patients, searched to October 2025.
Efficacy of topical treatments for mild-to-moderate acne: a systematic review and meta-analysis of randomized controlled trials
J Eur Acad Dermatol Venereol (2025) · Meta analysis · n=33472
35 randomised clinical trials, 33,472 participants, nine topical agents, minimum 12 weeks of treatment.
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
J Am Acad Dermatol (2010) · Meta analysis · n=7309
23 studies, 7,309 patients, conducted under Cochrane guidance and reported to PRISMA.
Clascoterone has a higher evidence score (7/10 vs 6.5/10) and wins in 1 of 3 categories.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 62).
No known interactions between Clascoterone and Clindamycin (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.